The #1 prescribed treatment for
HD chorea1
1st and only VMAT2 inhibitor approved for both HD chorea and TD2

Before you prescribed AUSTEDO for her Huntington’s disease (HD) chorea, she was concerned about people noticing her movements.2

Now holding on
to
the moment is
what
moves her

Woman and man smiling while gardening. “Now holding onto the moment is what moves her” appears next to them.
Woman and man smiling while gardening. “Now holding onto the moment is what moves her” appears next to them.

Mechanism of Action:

VMAT2 inhibition can help regulate dopamine function.4

TD, tardive dyskinesia; VMAT2, vesicular monoamine transporter 2.

REFERENCES: 1. Data on file. Parsippany, NJ: Teva Neuroscience, Inc. 2. AUSTEDO® (deutetrabenazine) tablets current Prescribing Information. Parsippany, NJ: Teva Neuroscience, Inc. 3. Frank S, Testa CM, Stamler D, et al; Huntington Study Group ARC-HD Investigators. Long-term efficacy and safety of deutetrabenazine for chorea in Huntington’s disease: results from the ARC-HD open-label study. Presented at: 27th Annual Meeting of the Huntington Study Group; October 29-31, 2020. 4. Frank S, Testa CM, Stamler D, et al; Huntington Study Group. Effect of deutetrabenazine on chorea among patients with Huntington disease: a randomized clinical trial. JAMA. 2016;316(1):40-50.